Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

75.04
Delayed Data
As of Sep 19
 -0.96 / -1.26%
Today’s Change
31.38
Today|||52-Week Range
89.45
+100.43%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sanofi
Buy5/31/2017297,501$71.87$21.4M+14.63%
Vaishnaw Akshay K
Senior Vice President-Research & Development
Sale5/15/201732,750$65.00$2.1M+13.70%
Greene Barry E
President
Buy12/01/201655,605$22.75$1.3M+80.47%
Pyott David E I
Director
Buy10/13/201627,900$37.00$1.0M+107.46%
Vaishnaw Akshay K
Senior Vice President-Research & Development
Buy5/15/201732,750$31.39$1.0M+13.70%
Maraganore John M
Chief Executive Officer
Sale12/12/201622,710$42.61$967.7K+76.11%
Vaishnaw Akshay K
EVP-Research & Development
Sale5/23/201711,000$75.00$825.0K+0.23%
Sharp Phillip Allen
Director
Sale2/01/201720,171$39.72$801.2K+85.51%
Sharp Phillip Allen
Director
Buy2/01/201725,000$31.29$782.3K+85.51%
Keating Laurie Bartlett
Secretary, Senior Vice President & General Counsel
Buy5/30/201711,500$65.35$751.5K+17.09%
Page of 4